-+ 0.00%
-+ 0.00%
-+ 0.00%

Pharmanutra Net Cash Falls to EUR 5.4 Million From EUR 11.4 Million at End-2025

PUBT·11/09/2026 17:02:23
Listen to the news
Pharmanutra Net Cash Falls to EUR 5.4 Million From EUR 11.4 Million at End-2025
  • Pharmanutra's net cash fell to EUR 5.4 million at September 30, 2026, from EUR 11.4 million at December 31, 2025.
  • Dividend payments of EUR 11.5 million were the main driver of the decline.
  • Capital expenditure of about EUR 4.4 million also reduced net cash, alongside EUR 800,000 in treasury share buybacks.
  • Financial assets increased through investments in a project related to the Cetilar brand.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmanutra S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 159723.pdf), on November 09, 2026, and is solely responsible for the information contained therein.